2026 Q3 Portfolio Activity
In 2026 Q3, SECTOR GAMMA AS maintained a portfolio of 47 distinct positions. The most significant new addition was DANAHER CORP DEL, now representing 2.90% of the total fund value. They heavily accumulated shares in PFIZER INC, increasing the position by 26.2%. Conversely, SECTOR GAMMA AS completely exited their position in THERMO FISHER SCIENTIFIC INC.
Position History
hover any row below to update
Loading…
Total Positions
47
Quarter
2026 Q3
Top Holding
BMY (7.9%)
Top 10 Concentration
48.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-47 of 47
SECTOR GAMMA AS Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BMY
BRISTOL-MYERS S...
|
Healthcare | 7.89% | 9.08% |
#1
Prev: #1
|
5.7 |
—
|
-113,153 | -15.6% |
P
S
|
612,962 | $38,248,829 | 2009 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
PFE
PFIZER INC
|
Healthcare | 7.45% | 5.25% |
#2
2
Prev: #4
|
7.0 |
—
|
263,119 | 26.2% |
P
S
|
1,267,334 | $36,144,366 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
MDT
MEDTRONIC PLC
|
Healthcare | 6.78% | 5.98% |
#3
Prev: #3
|
5.7 |
—
|
28,808 | 8.2% |
P
S
|
381,245 | $32,897,631 | 2009 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
MRK
MERCK & CO INC
|
Healthcare | 5.78% | 6.05% |
#4
2
Prev: #2
|
3.3 |
—
|
-23,964 | -11.0% |
P
S
|
193,044 | $28,051,224 | 2011 Q1 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
INCY
INCYTE CORP
|
Healthcare | 3.88% | 4.20% |
#5
Prev: #5
|
2.6 |
—
|
-15,653 | -9.2% |
P
S
|
155,100 | $18,821,385 | 2011 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 3.63% | 3.66% |
#6
1
Prev: #7
|
2.0 |
—
|
-1,625 | -0.6% |
P
S
|
293,293 | $17,597,580 | 2009 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
CVS
CVS HEALTH CORP
|
Healthcare | 3.47% | 3.49% |
#7
2
Prev: #9
|
3.9 |
—
|
41,237 | 26.5% |
P
S
|
196,574 | $16,844,426 | 2009 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
GEHC
GE HEALTHCARE T...
|
Healthcare | 3.46% | 2.89% |
#8
6
Prev: #14
|
3.9 |
—
|
49,043 | 23.6% |
P
S
|
256,906 | $16,793,945 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
ELV
ELEVANCE HEALTH...
|
Healthcare | 3.23% | 3.73% |
#9
3
Prev: #6
|
1.8 |
—
|
-4,270 | -9.6% |
P
S
|
40,229 | $15,641,840 | 2016 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
BIIB
BIOGEN INC
|
Healthcare | 3.10% | 2.54% |
#10
6
Prev: #16
|
3.7 |
—
|
12,483 | 23.0% |
P
S
|
66,646 | $15,053,998 | 2009 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 3.04% | 3.26% |
#11
Prev: #11
|
4.2 |
—
|
140,569 | 74.2% |
P
S
|
330,037 | $14,736,152 | 2017 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
BRKR
BRUKER CORP
|
Healthcare | 2.90% | 1.99% |
#12
11
Prev: #23
|
3.7 |
—
|
65,000 | 42.7% |
P
S
|
217,352 | $14,073,542 | 2019 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
DHR
DANAHER CORP DE...
|
Healthcare | 2.90% | — |
#13
Prev: #—
|
4.7 |
—
|
63,381 | — |
NEW
|
63,381 | $14,042,061 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
ABT
ABBOTT LABORATO...
|
Healthcare | 2.89% | 2.90% |
#14
1
Prev: #13
|
1.7 |
—
|
-5,703 | -3.9% |
P
S
|
141,741 | $14,008,263 | 2009 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
BDX
BECTON DICKINSO...
|
Healthcare | 2.79% | 3.06% |
#15
3
Prev: #12
|
1.6 |
—
|
-17,538 | -18.8% |
P
S
|
75,630 | $13,537,770 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 2.77% | 1.12% |
#16
15
Prev: #31
|
4.1 |
—
|
187,000 | 154.4% |
P
S
|
308,128 | $13,449,787 | 2009 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
BIO
BIO RAD LABS IN...
|
Healthcare | 2.60% | 2.12% |
#17
3
Prev: #20
|
2.0 |
—
|
no change | no change |
P
S
|
33,350 | $12,596,629 | 2013 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
ZBH
ZIMMER BIOMET H...
|
Healthcare | 2.41% | 2.66% |
#18
3
Prev: #15
|
1.5 |
—
|
-10,823 | -7.6% |
P
S
|
131,484 | $11,679,724 | 2009 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
IQV
IQVIA HLDGS INC
|
Healthcare | 2.34% | 3.27% |
#19
9
Prev: #10
|
0.9 |
—
|
-35,661 | -45.8% |
P
S
|
42,283 | $11,367,785 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 2.22% | 2.13% |
#20
1
Prev: #19
|
1.4 |
—
|
-1,596 | -10.1% |
P
S
|
14,184 | $10,755,302 | 2018 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
QGEN
QIAGEN NV
|
Healthcare | 2.09% | 2.44% |
#21
4
Prev: #17
|
1.3 |
—
|
-56,470 | -19.6% |
P
S
|
231,170 | $10,115,999 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
LH
LABCORP HOLDING...
|
Healthcare | 1.97% | 1.58% |
#22
4
Prev: #26
|
2.8 |
—
|
5,000 | 19.2% |
P
S
|
31,019 | $9,557,264 | 2009 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
AVTR
AVANTOR INC
|
Healthcare | 1.88% | 1.95% |
#23
1
Prev: #24
|
0.8 |
—
|
-300,000 | -33.1% |
P
S
|
606,088 | $9,121,624 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
CAH
CARDINAL HEALTH...
|
Healthcare | 1.85% | 2.10% |
#24
3
Prev: #21
|
1.2 |
—
|
-388 | -1.0% |
P
S
|
40,301 | $8,966,973 | 2009 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
CNC
CENTENE CORP DE...
|
Healthcare | 1.82% | 2.26% |
#25
7
Prev: #18
|
1.2 |
—
|
-20,000 | -12.3% |
P
S
|
142,405 | $8,846,199 | 2012 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 1.51% | — |
#26
Prev: #—
|
4.1 |
—
|
20,000 | — |
NEW
|
20,000 | $7,341,600 | 2009 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
AZNCF
ASTRAZENECA PLC
|
Unknown | 1.50% | — |
#27
Prev: #—
|
4.1 |
—
|
45,049 | — |
NEW
|
45,049 | $7,274,062 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 1.50% | 1.77% |
#28
3
Prev: #25
|
2.6 |
—
|
12,000 | 12.0% |
P
S
|
112,000 | $7,255,360 | 2019 Q1 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
IOVA
IOVANCE BIOTHER...
|
Healthcare | 1.19% | 0.87% |
#29
7
Prev: #36
|
0.5 |
—
|
-580,000 | -59.9% |
P
S
|
388,466 | $5,757,066 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
EW
EDWARDS LIFESCI...
|
Healthcare | 1.08% | 1.19% |
#30
1
Prev: #29
|
1.4 |
—
|
no change | no change |
P
S
|
60,402 | $5,213,901 | 2013 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
KURA
KURA ONCOLOGY I...
|
Healthcare | 0.96% | 1.03% |
#31
1
Prev: #32
|
1.4 |
—
|
no change | no change |
P
S
|
433,012 | $4,637,559 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 0.94% | 1.15% |
#32
2
Prev: #30
|
1.4 |
—
|
no change | no change |
P
S
|
241,739 | $4,544,693 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
TNDM
TANDEM DIABETES...
|
Healthcare | 0.90% | 0.87% |
#33
2
Prev: #35
|
1.4 |
—
|
no change | no change |
P
S
|
267,091 | $4,356,254 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
HCA
HCA HEALTHCARE ...
|
Healthcare | 0.88% | — |
#34
Prev: #—
|
3.9 |
—
|
10,000 | — |
NEW
|
10,000 | $4,267,400 | 2020 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 0.86% | 1.23% |
#35
7
Prev: #28
|
0.8 |
—
|
-3,000 | -14.1% |
P
S
|
18,305 | $4,170,428 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 0.83% | 0.99% |
#36
3
Prev: #33
|
0.8 |
—
|
-12,000 | -15.0% |
P
S
|
68,000 | $4,003,840 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 0.68% | — |
#37
Prev: #—
|
3.8 |
—
|
6,500 | — |
NEW
|
6,500 | $3,275,740 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 0.61% | 0.83% |
#38
1
Prev: #37
|
1.2 |
—
|
no change | no change |
P
S
|
45,000 | $2,965,950 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
DNLI
DENALI THERAPEU...
|
Healthcare | 0.59% | — |
#39
Prev: #—
|
3.7 |
—
|
137,718 | — |
NEW
|
137,718 | $2,846,631 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
ARDX
ARDELYX INC
|
Healthcare | 0.48% | 0.76% |
#40
1
Prev: #39
|
1.2 |
—
|
no change | no change |
P
S
|
686,844 | $2,349,006 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 0.36% | — |
#41
Prev: #—
|
3.6 |
—
|
84,867 | — |
NEW
|
84,867 | $1,747,412 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
NTLA
INTELLIA THERAP...
|
Healthcare | 0.00% | 0.68% |
Sold All 😨
(Was: #40) |
0.0 |
—
|
-185,177 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
OGN
ORGANON & CO
|
Healthcare | 0.00% | 0.80% |
Sold All 😨
(Was: #38) |
0.0 |
—
|
-270,781 | -100.0% |
CLOSED
|
— | $— | 2021 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 0.00% | 0.93% |
Sold All 😨
(Was: #34) |
0.0 |
—
|
-114,628 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
DXCM
DEXCOM INC
|
Healthcare | 0.00% | 1.49% |
Sold All 😨
(Was: #27) |
0.0 |
—
|
-102,122 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
AMGN
AMGEN INC
|
Healthcare | 0.00% | 2.06% |
Sold All 😨
(Was: #22) |
0.0 |
—
|
-26,281 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
TMO
THERMO FISHER S...
|
Healthcare | 0.00% | 3.65% |
Sold All 😨
(Was: #8) |
0.0 |
—
|
-33,584 | -100.0% |
CLOSED
|
— | $— | 2009 Q3 | 13F Filing | 2026-09-30 | 2026-11-12 |
Showing 1-47 of 47 holdings